_id

690db1d5ccc777a4e85d0c1c

Ticker

ASND

Name

Ascendis Pharma AS

Exchange

NASDAQ

Address

Tuborg Boulevard 12, Hellerup, Denmark, 2900

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://ascendispharma.com

Description

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

Last Close

210.16

Volume

678590

Current Price

220.42

Change

4.88199467072706

Last Updated

2025-11-28T12:27:16.644Z

Image

data:image/webp;base64,UklGRtQFAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSCIEAAANuS5E9D9EdLT/WuM6F8I3zMzMuIHsJ5vLFtKnSpWOmZlTjMYgPU/qf+iE1Fv9OFDqwulOYS1g3M/tFTrdCaj3LMALUPMtwOrtXqFSga+3AuVMLwciJmACtsXr8e12YnavwUueUb7qYGFisAGMHRRiJjBTtVEoDuQgBhyAX2ECZRMiEIzdoexZNh/MbAboQcxMABaIGYQhIgJSBvuY5sCDHYsZHCBmjBfIy8QZm4gDM4FjRt9DHKntw2AYmFUJEMAMwsRmJkINhIU9M2b9nOcF+F0ULyISB5aSTAxgMBlYAYsd5v4pj7gDwNnhShERYmERMjGBgjlmzLdN8sxDzxQ/LH1c49WxGDJGiJ92n8Nc7wmVcZOuMhSht0GajEfdZW51lzJ1iOLwu/Zq6QDLlEqFCNpQqnE6AGobnAARlIc8afka9QjAAIoI0neaHGE9B4B7uS4C6/fQjb+/y9E7MoS/W4qr6VeGQOLQyf9fHedoJ9uHvqQMC5M1Q66mxT70VxjCLGuPKS4wna4jquWjtGrbNUFfdRYqud++anqD0QT9j1UM0xBZPtQqWTZD/3ZcT5rw1A+oi7NNTdA/eVd+/+52FharJ75Kqk1B352SOG8mo8aHg4afus+mW8MaffkkWTO5zapbPkMWim6oWdwWX6Evx2NJ8y45BY/Gfv5oWK9tbHzmXYe+xyt0dLdBeSIGRHm+LB262FdFaQhmP0YpaX0UB2DVeTc/6fo+HU8Xq5Ucwfp9xt3vg3RaoVfheR7MuoGPfZutGIJdXEnOXb3sESyqmHNauB/Hi8nYr6QI3lhmqtdWy3GLvjbRnfK5MWpGGnORZQuGQM5aKrlM07HHTA1MczFKl9hVp6qUrEOvLnqWrh7mtt9jxuad2GxMJCUXs890QuhV9TE1mue5OMUsjRmzXE03jbPFInOygsBF56VJ1zuS1mH2LDYDM7OUnDBnsQ0EALNqQZIjz/PKM+aSnAqWR8bougVmxIuFU15Bb1IpieWDjkSnjDluYk6xmRFG5IUZWWy1GJTNF9IwmZV55hVzXpLzwC1uVE+8TzID1QDGCicou7wunfE4wXzmWmQ1RlojLrgWuDaNx13KyiJN6cfKmGcxJ8AW73bWsgkr2maJxBowEkYIVUmAS7HzJg2ZqXHZNN4nirCaCnATq9GJGQuZqxghphpqwIaRNOScMiP8bMDNzLRAJFWZAHzFpBINUkWgQ0RLpw0AUoZFoik1EwAKQzRTbosaURbnBADYjKPh2KjHwIik1QwJUIsGRJz1pObRREFMEbDClaxGwS80it51jhlRHBZxE7DElToK38/Dy8VdANvAfb9pxGEyXRgmuywh8N1ynz/P4gojzLLg32qJgvZTzmmOkPsiWWgQfAzbwpIbu1BlrR806M9W1yQINQ0wU1ZQOCCMAQAAEAkAnQEqQABAAD61VqNNJySjIiQLaOAWiWIAzJOM2AUbIANtHz3Pnq74BvI6NsyAavIQ3q5pXvgUK0zk6gmDLnBPT4pV+wQEi17oBd3Q2IAAAP7C46/PxeA4DhygpEv4DywE8TcrXxqfX8gm8m/6XBdL46jq9QB/wZZmKj14Tcz7u0Vor3w8AzIX5MNcqd9/DLi3edTdvNUCNHg1vN+y+lz/Do+M5S17AsnhE9+Mxu9rvsDFx7ehDYZmO850WyS2QDIAW0Hj+IW/AovZka7yH2Gh8r7wYBPe1Ea0RVr/ehf1P/RPSRCL8EI7THAAt1Mnk6relGwuBFkBU7lngAue5oYbGTNZnDESDwBGkpZ9yJt62SWOSS/9AjEy42KiRh/g8BzM5F62SZewVPr298fCRCfsD/SyionteMU1b3QH27LucPiSvBON/oHQxoWzcf2UMTxlYVoSf60bMJCS9i7dFlbhp1GCnH7V8G61yVmgAV+k5pECmkYoYNUHl/arVQ78iN8c51/h1WldpUAA

Ipo Date

2015-01-28T00:00:00.000Z

Market Cap

12831223808

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.89664

Sentiment Sources

25

Rating

4.75

Target Price

257.5097

Strong Buy

12

Buy

4

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

213634000

Cost Of Revenue

22354000

Gross Profit

191280000

Operating Expenses

180283000

Operating Income

10997000

Interest Expense

19721000

Pretax Income

-57372000

Net Income

-60989000

Eps

-1

Dividends Per Share

-

Shares Outstanding

61098156

Income Tax Expense

3617000

EBITDA

-53353000

Operating Margin

5.147588866940655

Total Other Income Expense Net

-68369000

Cash

539092000

Short Term Investments

-

Receivables

134734000

Inventories

302022000

Total Current Assets

1017781000

Property Plant Equipment

101764000

Total Assets

1154750000

Payables

78601000

Short Term Debt

482281000

Long Term Debt

331369000

Total Liabilities

1328825000

Equity

-174075000

Depreciation

4019000

Change In Working Capital

24642000

Cash From Operations

2153000

Capital Expenditures

53000

Cash From Investing

-53000

Cash From Financing

38854000

Net Change In Cash

45046000

PE

-

PB

-77.22645629757288

ROE

35.03604768059744

ROA

-5.281576098722667

FCF

2100000

Fcf Percent

0.009829895990338617

Piotroski FScore

2

Health Score

31

Deep Value Investing Score

2.5

Defensive Investing Score

7

Dividend Investing Score

3

Economic Moat Investing Score

7.8

Garp Investing Score

6

Growth Investing Score

6

Momentum Investing Score

3

Net Net Investing Score

2

Quality Investing Score

4.5

Value Investing Score

3

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

213634000

Quarters > 0 > income Statement > cost Of Revenue

22354000

Quarters > 0 > income Statement > gross Profit

191280000

Quarters > 0 > income Statement > operating Expenses

180283000

Quarters > 0 > income Statement > operating Income

10997000

Quarters > 0 > income Statement > interest Expense

19721000

Quarters > 0 > income Statement > pretax Income

-57372000

Quarters > 0 > income Statement > net Income

-60989000

Quarters > 0 > income Statement > eps

-1

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

60989000

Quarters > 0 > income Statement > income Tax Expense

3617000

Quarters > 0 > income Statement > EBITDA

-53353000

Quarters > 0 > income Statement > operating Margin

5.147588866940655

Quarters > 0 > income Statement > total Other Income Expense Net

-68369000

Quarters > 0 > balance Sheet > cash

539092000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

134734000

Quarters > 0 > balance Sheet > inventories

302022000

Quarters > 0 > balance Sheet > total Current Assets

1017781000

Quarters > 0 > balance Sheet > property Plant Equipment

101764000

Quarters > 0 > balance Sheet > total Assets

1154750000

Quarters > 0 > balance Sheet > payables

78601000

Quarters > 0 > balance Sheet > short Term Debt

482281000

Quarters > 0 > balance Sheet > long Term Debt

331369000

Quarters > 0 > balance Sheet > total Liabilities

1328825000

Quarters > 0 > balance Sheet > equity

-174075000

Quarters > 0 > cash Flow > net Income

-60990000

Quarters > 0 > cash Flow > depreciation

4019000

Quarters > 0 > cash Flow > change In Working Capital

24642000

Quarters > 0 > cash Flow > cash From Operations

2153000

Quarters > 0 > cash Flow > capital Expenditures

53000

Quarters > 0 > cash Flow > cash From Investing

-53000

Quarters > 0 > cash Flow > cash From Financing

38854000

Quarters > 0 > cash Flow > net Change In Cash

45046000

Quarters > 0 > ratios > PE

-1

Quarters > 0 > ratios > PB

-77.22645629757288

Quarters > 0 > ratios > ROE

35.03604768059744

Quarters > 0 > ratios > ROA

-5.281576098722667

Quarters > 0 > ratios > FCF

2100000

Quarters > 0 > ratios > Piotroski FScore

2

Quarters > 0 > ratios > fcf Percent

0.009829895990338617

Quarters > 0 > health Score

31

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

158045000

Quarters > 1 > income Statement > cost Of Revenue

31447000

Quarters > 1 > income Statement > gross Profit

126598000

Quarters > 1 > income Statement > operating Expenses

179549000

Quarters > 1 > income Statement > operating Income

-52951000

Quarters > 1 > income Statement > interest Expense

33018000

Quarters > 1 > income Statement > pretax Income

-35007000

Quarters > 1 > income Statement > net Income

-38855000

Quarters > 1 > income Statement > eps

-0.607951254498143

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

63911374

Quarters > 1 > income Statement > income Tax Expense

3848000

Quarters > 1 > income Statement > EBITDA

2319000

Quarters > 1 > income Statement > operating Margin

-33.50374893226613

Quarters > 1 > income Statement > total Other Income Expense Net

17944000

Quarters > 1 > balance Sheet > cash

494046000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

110452000

Quarters > 1 > balance Sheet > inventories

303381000

Quarters > 1 > balance Sheet > total Current Assets

952957000

Quarters > 1 > balance Sheet > property Plant Equipment

93542000

Quarters > 1 > balance Sheet > total Assets

1087902000

Quarters > 1 > balance Sheet > payables

93718000

Quarters > 1 > balance Sheet > short Term Debt

462348000

Quarters > 1 > balance Sheet > long Term Debt

330186000

Quarters > 1 > balance Sheet > total Liabilities

1275474000

Quarters > 1 > balance Sheet > equity

-187572000

Quarters > 1 > cash Flow > net Income

-38856000

Quarters > 1 > cash Flow > depreciation

4308000

Quarters > 1 > cash Flow > change In Working Capital

-44027000

Quarters > 1 > cash Flow > cash From Operations

-7341000

Quarters > 1 > cash Flow > capital Expenditures

4338000

Quarters > 1 > cash Flow > cash From Investing

-4338000

Quarters > 1 > cash Flow > cash From Financing

6981000

Quarters > 1 > cash Flow > net Change In Cash

-23877000

Quarters > 1 > ratios > PE

-0.607951254498143

Quarters > 1 > ratios > PB

-75.10366716290277

Quarters > 1 > ratios > ROE

20.714712217175272

Quarters > 1 > ratios > ROA

-3.5715533200600786

Quarters > 1 > ratios > FCF

-11679000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-0.07389667499762725

Quarters > 1 > health Score

31

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

100954000

Quarters > 2 > income Statement > cost Of Revenue

17517000

Quarters > 2 > income Statement > gross Profit

83437000

Quarters > 2 > income Statement > operating Expenses

187649000

Quarters > 2 > income Statement > operating Income

-104212000

Quarters > 2 > income Statement > interest Expense

44786000

Quarters > 2 > income Statement > pretax Income

-93565000

Quarters > 2 > income Statement > net Income

-94626000

Quarters > 2 > income Statement > eps

-1.5766125639489792

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

60018550

Quarters > 2 > income Statement > income Tax Expense

1061000

Quarters > 2 > income Statement > EBITDA

-44234000

Quarters > 2 > income Statement > operating Margin

-103.2272123937635

Quarters > 2 > income Statement > total Other Income Expense Net

10647000

Quarters > 2 > balance Sheet > cash

517923000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

66685000

Quarters > 2 > balance Sheet > inventories

293071000

Quarters > 2 > balance Sheet > total Current Assets

921487000

Quarters > 2 > balance Sheet > property Plant Equipment

92447000

Quarters > 2 > balance Sheet > total Assets

1061438000

Quarters > 2 > balance Sheet > payables

84370000

Quarters > 2 > balance Sheet > short Term Debt

489960000

Quarters > 2 > balance Sheet > long Term Debt

357312000

Quarters > 2 > balance Sheet > total Liabilities

1251245000

Quarters > 2 > balance Sheet > equity

-189807000

Quarters > 2 > cash Flow > net Income

-94626000

Quarters > 2 > cash Flow > depreciation

4545000

Quarters > 2 > cash Flow > change In Working Capital

50488000

Quarters > 2 > cash Flow > cash From Operations

-14313000

Quarters > 2 > cash Flow > capital Expenditures

703000

Quarters > 2 > cash Flow > cash From Investing

-703000

Quarters > 2 > cash Flow > cash From Financing

-18024000

Quarters > 2 > cash Flow > net Change In Cash

-41620000

Quarters > 2 > ratios > PE

-1.5766125639489792

Quarters > 2 > ratios > PB

-69.69863488174829

Quarters > 2 > ratios > ROE

49.85379885884082

Quarters > 2 > ratios > ROA

-8.914887162509727

Quarters > 2 > ratios > FCF

-15016000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-0.14874101075737464

Quarters > 2 > health Score

31

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

173916000

Quarters > 3 > income Statement > cost Of Revenue

14023000

Quarters > 3 > income Statement > gross Profit

159893000

Quarters > 3 > income Statement > operating Expenses

159510000

Quarters > 3 > income Statement > operating Income

383000

Quarters > 3 > income Statement > interest Expense

56628000

Quarters > 3 > income Statement > pretax Income

-37384000

Quarters > 3 > income Statement > net Income

-38469000

Quarters > 3 > income Statement > eps

-0.6434539296921915

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

59785166

Quarters > 3 > income Statement > income Tax Expense

1085000

Quarters > 3 > income Statement > EBITDA

-37893000

Quarters > 3 > income Statement > operating Margin

0.22022125623864394

Quarters > 3 > income Statement > total Other Income Expense Net

-37767000

Quarters > 3 > balance Sheet > cash

559543000

Quarters > 3 > balance Sheet > short Term Investments

0

Quarters > 3 > balance Sheet > receivables

166280000

Quarters > 3 > balance Sheet > inventories

295609000

Quarters > 3 > balance Sheet > total Current Assets

1060861000

Quarters > 3 > balance Sheet > property Plant Equipment

98714000

Quarters > 3 > balance Sheet > total Assets

1179495000

Quarters > 3 > balance Sheet > payables

96394000

Quarters > 3 > balance Sheet > short Term Debt

491536000

Quarters > 3 > balance Sheet > long Term Debt

365080000

Quarters > 3 > balance Sheet > total Liabilities

1285201000

Quarters > 3 > balance Sheet > equity

-105706000

Quarters > 3 > cash Flow > net Income

-38469000

Quarters > 3 > cash Flow > depreciation

4475000

Quarters > 3 > cash Flow > change In Working Capital

-44393000

Quarters > 3 > cash Flow > cash From Operations

-87176000

Quarters > 3 > cash Flow > capital Expenditures

383000

Quarters > 3 > cash Flow > cash From Investing

-384000

Quarters > 3 > cash Flow > cash From Financing

87000

Quarters > 3 > cash Flow > net Change In Cash

-65972000

Quarters > 3 > ratios > PE

-0.6434539296921915

Quarters > 3 > ratios > PB

-124.66507378691843

Quarters > 3 > ratios > ROE

36.39244697557376

Quarters > 3 > ratios > ROA

-3.261480548878969

Quarters > 3 > ratios > FCF

-87559000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-0.5034556912532487

Quarters > 3 > health Score

30

Valuation > metrics > PE

-1

Valuation > metrics > PB

-77.22645629757288

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

35.03604768059744

Profitability > metrics > ROA

-5.9923500242193555

Profitability > metrics > Net Margin

-0.2854835840736961

Profitability > final Score

40

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

0.557628923482582

Risk > final Score

32

Risk > verdict

High

Liquidity > metrics > Current Ratio

1.8146080637281996

Liquidity > metrics > Quick Ratio

1.2761311648439422

Liquidity > final Score

95

Liquidity > verdict

Great

Prev Valuations > 0

50

Prev Valuations > 1

50

Prev Valuations > 2

50

Prev Profitabilities > 0

40

Prev Profitabilities > 1

40

Prev Profitabilities > 2

40

Prev Risks > 0

24

Prev Risks > 1

21

Prev Risks > 2

30

Prev Liquidities > 0

93

Prev Liquidities > 1

90

Prev Liquidities > 2

95

Updated At

2025-12-14T00:14:40.838Z